{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T14:08:41Z","timestamp":1648908521894},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T00:00:00Z","timestamp":1276041600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00393-010-0627-z","type":"journal-article","created":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T09:34:40Z","timestamp":1275903280000},"page":"527-538","source":"Crossref","is-referenced-by-count":2,"title":["Lysosomale Speicherkrankheiten"],"prefix":"10.1007","volume":"69","author":[{"given":"B.","family":"Manger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"627_CR1","unstructured":"http:\/\/www.ec.europa.eu\/health\/ph_information\/documents\/ev20040705_rd05_en.pdf vom 12.1.2010"},{"key":"627_CR2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/art.1780260813","volume":"26","author":"Decker","year":"1983","unstructured":"Decker JL (1983) American Rheumatism Association nomenclature and classification of arthritis and rheumatism. Arthritis Rheum 26:1029\u20131032","journal-title":"Arthritis Rheum"},{"key":"627_CR3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10067-009-1117-z","volume":"28","author":"Manger","year":"2009","unstructured":"Manger K, N\u00fcsslein H, Schett G, Manger B (2009) Rare monogenetic syndromes in rheumatology practice. Clin Rheumatol 28:623\u2013630","journal-title":"Clin Rheumatol"},{"key":"627_CR4","unstructured":"http:\/\/www.merck.com\/media\/mmpe\/pdf\/Table_296-4w.pdf vom 12.1.2010"},{"key":"627_CR5","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2008.095315","volume":"68","author":"Aldenhoven","year":"2009","unstructured":"Aldenhoven M, Sakkers RJB, Boelens J et al (2009) Muskuloskelettal manifestations of lysosomal storage disorders. Ann Rheum Dis 68:1659\u20131665","journal-title":"Ann Rheum Dis"},{"key":"627_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1546-0096-7-18","volume":"7","author":"Cimaz","year":"2009","unstructured":"Cimaz R, Coppa GV, Kon\u00e9-Paut I et al (2009) Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J 7:18","journal-title":"Pediatr Rheumatol Online J"},{"key":"627_CR7","first-page":"23","volume":"3","author":"Manger","year":"2008","unstructured":"Manger B (2008) Rheumatological manifestations are key in the early diagnosis of mucopolysaccaridosis type I. Europ Musculoskel Rev 3:23\u201326","journal-title":"Europ Musculoskel Rev"},{"key":"627_CR8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF02222956","volume":"24","author":"Hurler","year":"1919","unstructured":"Hurler G (1919) \u00dcber einen Typ multipler Abartungen, vorwiegend am Skelettsystem. Z Kinderheilk 24:220\u2013234","journal-title":"Z Kinderheilk"},{"key":"627_CR9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0002-9394(62)91975-X","volume":"53","author":"Scheie","year":"1962","unstructured":"Scheie H, Hambrick G, Barnes L (1962) A newly recognized forme fruste of Hurler\u2019s disease (gargoylism). Am J Ophthalmol 53:753\u2013769","journal-title":"Am J Ophthalmol"},{"key":"627_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","volume":"91","author":"Pastores","year":"2007","unstructured":"Pastores GM, Arn Beck M et al (2007) The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with mucopolysaccharidosis type I. Mol Genet Metab 91:37\u201347","journal-title":"Mol Genet Metab"},{"key":"627_CR11","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/08035250510031584","volume":"94","author":"Vijay","year":"2005","unstructured":"Vijay S, Wraith JE (2005) Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr 94:872\u2013877","journal-title":"Acta Paediatr"},{"key":"627_CR12","first-page":"196","volume":"24","author":"Cimaz","year":"2006","unstructured":"Cimaz R, Vijay S, Haase C et al (2006) Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome. Clin Exp Rheumatol 24:196\u2013202","journal-title":"Clin Exp Rheumatol"},{"key":"627_CR13","first-page":"387","volume":"69","author":"Van","year":"2003","unstructured":"Van Meir, Smet L de (2003) Carpal tunnel syndrome in children. Acta Orthop Belg 69:387\u2013395","journal-title":"Acta Orthop Belg"},{"key":"627_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1442-200X.2003.01654.x","volume":"45","author":"Matsui","year":"2003","unstructured":"Matsui Y, Kawabata H, Nakayama M et al (2003) Scheie syndrome (MPS-IS) presented as bilateral trigger thumb. Pediatr Int 45:91\u201392","journal-title":"Pediatr Int"},{"key":"627_CR15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","volume":"144","author":"Wraith","year":"2004","unstructured":"Wraith JE, Clarke LA, Beck M et al (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144:581\u2013588","journal-title":"J Pediatr"},{"key":"627_CR16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","volume":"90","author":"Sifuentes","year":"2007","unstructured":"Sifuentes M, Doroshow R, Hoft R (2007) A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab 90:171\u2013180","journal-title":"Mol Genet Metab"},{"key":"627_CR17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/BOR.0b013e3282f169fe","volume":"20","author":"Michels","year":"2008","unstructured":"Michels H, Mengel E (2008) Lysosomal storage diseases as differential diagnoses to rheumatic disorders. Curr Opin Rheumatol 20:76\u201381","journal-title":"Curr Opin Rheumatol"},{"key":"627_CR18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U et al (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236\u2013242","journal-title":"Eur J Clin Invest"},{"key":"627_CR19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00393-006-0039-2","volume":"65","author":"Manger","year":"2006","unstructured":"Manger B, Mengel E, Schaefer R et al (2006) M.\u00a0Gaucher, M.\u00a0Fabry und Mukopolysaccharidose Typ\u00a0I. Z Rheumatol 65:32\u201343","journal-title":"Z Rheumatol"},{"key":"627_CR20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","volume":"146","author":"Clarke","year":"2007","unstructured":"Clarke JT (2007) Narrative review: Fabry disease. Ann Intern Med 146:425\u2013433","journal-title":"Ann Intern Med"},{"key":"627_CR21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2008-1027710","volume":"34","author":"Reinhold-Keller","year":"2009","unstructured":"Reinhold-Keller E, Horneff G, Sch\u00e4fer RM, Young P (2009) Differenzialdiagnose akraler Schmerzen: Junger Mann mit akralen Schmerzen, Fiebersch\u00fcben und H\u00f6rverlust. Akt Rheum 34:126\u2013131","journal-title":"Akt Rheum"},{"key":"627_CR22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10067-006-0299-x","volume":"26","author":"Manger","year":"2007","unstructured":"Manger B, Mengel E, Schaefer RM (2007) Rheumatologic aspects of lysosomal storage diseases. Clin Rheumatol 26:355\u2013341","journal-title":"Clin Rheumatol"},{"key":"627_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","volume":"30","author":"Eng","year":"2007","unstructured":"Eng CM, Fletcher J, Wilcox WR et al (2007) Fabry disease: baseline medical characteristics of a cohort of 1756 males and females in the Fabry Registry. J inherit Metab Dis 30:184\u2013192","journal-title":"J inherit Metab Dis"},{"key":"627_CR24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"Schiffmann","year":"2001","unstructured":"Schiffmann R, Koop JB, Austin HA III et al (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743\u20132749","journal-title":"JAMA"},{"key":"627_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR et al (2001) Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry\u2019s disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"627_CR26","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","volume":"62","author":"Thurberg","year":"2002","unstructured":"Thurberg BL, Rennke H, Colvin RB et al (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933\u20131946","journal-title":"Kidney Int"},{"key":"627_CR27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/art.1780250616","volume":"25","author":"Weizman","year":"1982","unstructured":"Weizman Z, Tennenbaum, Yatziv S (1982) Interphalangeal joint involvement in Gaucher\u2019s disease, type\u00a0I, resembling juvenile rheumatoid arthritis. Arthritis Rheum 25:706\u2013707","journal-title":"Arthritis Rheum"},{"key":"627_CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0029-1225343","volume":"34","author":"N\u00fc\u00dflein","year":"2009","unstructured":"N\u00fc\u00dflein HG, Huppertz HI, Massenkeil G, Mengel E (2009) Splenomegalie \u2013 ein wichtiges Leitsymptom. Akt Rheum 34:213\u2013219","journal-title":"Akt Rheum"},{"key":"627_CR29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","volume":"113","author":"Weinreb","year":"2002","unstructured":"Weinreb NJ, CharrowJ, Andersson HC et al (2002) Effectiveness of enzyme replacement therapy in 1028 patients with type I Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 113:112\u2013119","journal-title":"Am J Med"},{"key":"627_CR30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-2006-927311","volume":"31","author":"Mengel","year":"2006","unstructured":"Mengel E, Manger B (2006) Erste Ergebnisse der Fortbildungsinitiative zur Erkennung von lysosomalen Speicherkrankheiten in der rheumatologischen Praxis. Akt Rheum 31:307\u2013311","journal-title":"Akt Rheum"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-010-0627-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-010-0627-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-010-0627-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:36:01Z","timestamp":1559046961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-010-0627-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,9]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1007\/s00393-010-0627-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,9]]}}}